• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 H-MR 光谱和 IDH 野生型弥漫性星形细胞瘤无强化弥散加权成像的拉伸指数扩散模型预测 TERT 启动子突变状态。

Predicting TERT promoter mutation status using H-MR spectroscopy and stretched-exponential model of diffusion-weighted imaging in IDH-wildtype diffuse astrocytic glioma without intense enhancement.

机构信息

Departments of Radiology Informatics and Network, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan.

Departments of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan.

出版信息

Neuroradiology. 2023 Aug;65(8):1205-1213. doi: 10.1007/s00234-023-03177-y. Epub 2023 Jun 13.

DOI:10.1007/s00234-023-03177-y
PMID:37308686
Abstract

PURPOSE

Isocitrate dehydrogenase (IDH)-wildtype diffuse astrocytic glioma with telomerase reverse transcriptase (TERT) promoter mutation is defined as glioblastoma by the WHO 2021 criteria, revealing that TERT promotor mutation is highly associated with tumor aggressiveness. The aim of this study was to identify features from MR spectroscopy (MRS) and multi-exponential models of DWI distinguishing wild-type TERT (TERTw) from TERT promoter mutation (TERTm) in IDH-wildtype diffuse astrocytic glioma.

METHODS

Participants comprised 25 adult patients with IDH-wildtype diffuse astrocytic glioma. Participants were classified into TERTw and TERTm groups. Point-resolved spectroscopy sequences were used for MRS data acquisition. DWI was performed with 13 different b-factors. Peak height ratios of NAA/Cr and Cho/Cr were calculated from MRS data. Mean apparent diffusion coefficient (ADC), perfusion fraction (f), diffusion coefficient (D), pseudo-diffusion coefficient (D*), distributed diffusion coefficient (DDC), and heterogeneity index (α) were obtained using multi-exponential models from DWI data. Each parameter was compared between TERTw and TERTm using the Mann-Whitney U test. Correlations between parameters derived from MRS and DWI were also evaluated.

RESULTS

NAA/Cr and Cho/Cr were both higher for TERTw than for TERTm. The α of TERTw was smaller than that of TERTm, while the f of TERTw was higher than that of TERTm. NAA/Cr correlated negatively with α, but not with other DWI parameters. Cho/Cr did not show significant correlations with any DWI parameters.

CONCLUSION

The combination of NAA/Cr and α may have merit in clinical situation to predict the TERT mutation status of IDH-wildtype diffuse astrocytic glioma without intense enhancement.

摘要

目的

根据世界卫生组织 2021 年标准,端粒酶逆转录酶 (TERT) 启动子突变的异柠檬酸脱氢酶 (IDH)-野生型弥漫性星形细胞瘤被定义为胶质母细胞瘤,这表明 TERT 启动子突变与肿瘤侵袭性高度相关。本研究旨在确定磁共振波谱 (MRS) 和 DWI 多指数模型中的特征,以区分 IDH 野生型弥漫性星形细胞瘤中的野生型 TERT (TERTw) 和 TERT 启动子突变 (TERTm)。

方法

参与者包括 25 名 IDH 野生型弥漫性星形细胞瘤的成年患者。参与者被分为 TERTw 和 TERTm 组。使用点分辨波谱序列采集 MRS 数据。DWI 采用 13 种不同的 b 值进行。从 MRS 数据中计算出 NAA/Cr 和 Cho/Cr 的峰高比。使用 DWI 数据的多指数模型获得平均表观扩散系数 (ADC)、灌注分数 (f)、扩散系数 (D)、伪扩散系数 (D*)、分布扩散系数 (DDC) 和异质性指数 (α)。使用 Mann-Whitney U 检验比较 TERTw 和 TERTm 之间的每个参数。还评估了来自 MRS 和 DWI 的参数之间的相关性。

结果

TERTw 的 NAA/Cr 和 Cho/Cr 均高于 TERTm。TERTw 的 α 小于 TERTm,而 TERTw 的 f 高于 TERTm。NAA/Cr 与 α 呈负相关,但与其他 DWI 参数无关。Cho/Cr 与任何 DWI 参数均无显著相关性。

结论

在没有强烈增强的情况下,NAA/Cr 和 α 的组合可能在临床情况下具有预测 IDH 野生型弥漫性星形细胞瘤 TERT 突变状态的优势。

相似文献

1
Predicting TERT promoter mutation status using H-MR spectroscopy and stretched-exponential model of diffusion-weighted imaging in IDH-wildtype diffuse astrocytic glioma without intense enhancement.使用 H-MR 光谱和 IDH 野生型弥漫性星形细胞瘤无强化弥散加权成像的拉伸指数扩散模型预测 TERT 启动子突变状态。
Neuroradiology. 2023 Aug;65(8):1205-1213. doi: 10.1007/s00234-023-03177-y. Epub 2023 Jun 13.
2
Predicting TERT promoter mutation using MR images in patients with wild-type IDH1 glioblastoma.使用 IDH1 野生型胶质母细胞瘤患者的磁共振图像预测 TERT 启动子突变。
Diagn Interv Imaging. 2019 Jul-Aug;100(7-8):411-419. doi: 10.1016/j.diii.2019.02.010. Epub 2019 Apr 1.
3
Clinical Assessment of Magnetic Resonance Spectroscopy and Diffusion-Weighted Imaging in Diffuse Glioma: Insights Into Histological Grading and Classification.弥散性胶质瘤的磁共振波谱和弥散加权成像的临床评估:对组织学分级和分类的深入了解。
Can Assoc Radiol J. 2024 Nov;75(4):868-877. doi: 10.1177/08465371241238917. Epub 2024 Apr 5.
4
Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.弥散加权和灌注加权 MRI 放射组学模型可预测弥漫性低级别胶质瘤中的异柠檬酸脱氢酶 (IDH) 突变和肿瘤侵袭性。
Eur Radiol. 2020 Apr;30(4):2142-2151. doi: 10.1007/s00330-019-06548-3. Epub 2019 Dec 11.
5
Ultra-high b-value DWI accurately identifies isocitrate dehydrogenase genotypes and tumor subtypes of adult-type diffuse gliomas.超高 b 值 DWI 可准确识别成人弥漫性胶质瘤的异柠檬酸脱氢酶基因型和肿瘤亚型。
Eur Radiol. 2024 Oct;34(10):6751-6762. doi: 10.1007/s00330-024-10708-5. Epub 2024 Mar 25.
6
Diffusion and perfusion MRI may predict EGFR amplification and the TERT promoter mutation status of IDH-wildtype lower-grade gliomas.弥散和灌注 MRI 可预测 IDH 野生型低级别胶质瘤的 EGFR 扩增和 TERT 启动子突变状态。
Eur Radiol. 2020 Dec;30(12):6475-6484. doi: 10.1007/s00330-020-07090-3. Epub 2020 Aug 12.
7
Telomerase reverse transcriptase promoter mutation and histologic grade in IDH wild-type histological lower-grade gliomas: The value of perfusion-weighted image, diffusion-weighted image, and F-FDG-PET.异柠檬酸脱氢酶(IDH)野生型组织学低级别胶质瘤中端粒酶逆转录酶启动子突变与组织学分级:灌注加权成像、扩散加权成像及F-FDG-PET的价值
Eur J Radiol. 2023 Feb;159:110658. doi: 10.1016/j.ejrad.2022.110658. Epub 2022 Dec 19.
8
Noninvasively evaluating the grade and IDH mutation status of gliomas by using mono-exponential, bi-exponential diffusion-weighted imaging and three-dimensional pseudo-continuous arterial spin labeling.通过单指数、双指数扩散加权成像和三维准连续动脉自旋标记技术无创评估脑胶质瘤的分级和 IDH 突变状态。
Eur J Radiol. 2023 Mar;160:110721. doi: 10.1016/j.ejrad.2023.110721. Epub 2023 Feb 1.
9
Advanced MR imaging and F-DOPA PET characteristics of H3K27M-mutant and wild-type pediatric diffuse midline gliomas.H3K27M 突变型和野生型小儿弥漫性中线脑胶质瘤的高级 MRI 成像和 F-DOPA PET 特征。
Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1685-1694. doi: 10.1007/s00259-019-04333-4. Epub 2019 Apr 27.
10
Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects.3T 质子磁共振波谱、灌注和弥散成像在鉴别脑胶质瘤复发与治疗后改变中的比较。
J Magn Reson Imaging. 2012 Jan;35(1):56-63. doi: 10.1002/jmri.22801. Epub 2011 Oct 14.

引用本文的文献

1
Late enhancement and wash-out maps for differentiation of glioblastoma and metastases.用于鉴别胶质母细胞瘤和转移瘤的延迟强化及廓清图。
BMC Med Imaging. 2025 Aug 27;25(1):353. doi: 10.1186/s12880-025-01889-6.
2
[Research Progress in Imaging Investigation of TERT Promoter Mutations in Gliomas].[胶质瘤中TERT启动子突变的影像学研究进展]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Nov 20;55(6):1350-1356. doi: 10.12182/20241160501.
3
Research Progress on Glioma Microenvironment and Invasiveness Utilizing Advanced Multi-Parametric Quantitative MRI.

本文引用的文献

1
Value of DWI Combined with Magnetic Resonance Spectroscopy in the Differential Diagnosis between Recurrent Glioma and Radiation Injury: A Meta-Analysis.DWI 联合磁共振波谱在复发性脑胶质瘤与放射性损伤鉴别诊断中的价值:Meta 分析。
Int J Clin Pract. 2022 Oct 25;2022:1629570. doi: 10.1155/2022/1629570. eCollection 2022.
2
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.2021 年世卫组织中枢神经系统肿瘤分类:概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
3
TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma.
利用先进的多参数定量磁共振成像对胶质瘤微环境与侵袭性的研究进展
Cancers (Basel). 2024 Dec 29;17(1):74. doi: 10.3390/cancers17010074.
端粒酶逆转录酶(TERT)启动子突变状态对于诊断具有胶质母细胞瘤分子特征的异柠檬酸脱氢酶(IDH)野生型弥漫性星形细胞胶质瘤而言是必要且充分的。
Acta Neuropathol. 2021 Aug;142(2):323-338. doi: 10.1007/s00401-021-02337-9. Epub 2021 Jun 20.
4
Combined application of MRS and DWI can effectively predict cell proliferation and assess the grade of glioma: A prospective study.联合 MRS 和 DWI 应用可有效预测胶质瘤细胞增殖并评估肿瘤级别:一项前瞻性研究。
J Clin Neurosci. 2021 Jan;83:56-63. doi: 10.1016/j.jocn.2020.11.030. Epub 2020 Dec 15.
5
Characterization of tumors with ultralow tumor mutational burden in Japanese cancer patients.日本癌症患者中具有超低肿瘤突变负担的肿瘤特征。
Cancer Sci. 2020 Oct;111(10):3893-3901. doi: 10.1111/cas.14572. Epub 2020 Aug 7.
6
Differentiation of high-grade from low-grade diffuse gliomas using diffusion-weighted imaging: a comparative study of mono-, bi-, and stretched-exponential diffusion models.使用弥散加权成像区分高级别和低级别弥漫性胶质瘤:单指数、双指数和拉伸指数弥散模型的比较研究。
Neuroradiology. 2020 Jul;62(7):815-823. doi: 10.1007/s00234-020-02456-2. Epub 2020 May 18.
7
Intravoxel Incoherent Motion MR Imaging of Pediatric Intracranial Tumors: Correlation with Histology and Diagnostic Utility.儿童颅内肿瘤的体素内不相干运动磁共振成像:与组织学的相关性和诊断效用。
AJNR Am J Neuroradiol. 2019 May;40(5):878-884. doi: 10.3174/ajnr.A6052. Epub 2019 Apr 25.
8
Doomed from the TERT? A Two-Stage Model of Tumorigenesis in IDH-Wild-Type Glioblastoma.从 TERT 注定?IDH 野生型胶质母细胞瘤的两阶段肿瘤发生模型。
Cancer Cell. 2019 Apr 15;35(4):542-544. doi: 10.1016/j.ccell.2019.03.009.
9
False-Positive Measurement at 2-Hydroxyglutarate MR Spectroscopy in Isocitrate Dehydrogenase Wild-Type Glioblastoma: A Multifactorial Analysis.2-羟戊二酸磁共振波谱在异柠檬酸脱氢酶野生型胶质母细胞瘤中假阳性测量:多因素分析。
Radiology. 2019 Jun;291(3):752-762. doi: 10.1148/radiol.2019182200. Epub 2019 Apr 16.
10
Predicting TERT promoter mutation using MR images in patients with wild-type IDH1 glioblastoma.使用 IDH1 野生型胶质母细胞瘤患者的磁共振图像预测 TERT 启动子突变。
Diagn Interv Imaging. 2019 Jul-Aug;100(7-8):411-419. doi: 10.1016/j.diii.2019.02.010. Epub 2019 Apr 1.